Literature DB >> 32958871

Predictors and ocular outcomes of rescue treatment in preterm infants with treated retinopathy of prematurity-a retrospective study.

Haribalakrishna Balasubramanian1, Mythily Sindhur2, Ashish Doshi2, Lakshmi Srinivasan3, Nandkishor S Kabra2, Anupam Malpani2, Prachi Agashe2.   

Abstract

AIM: To determine predictors of rescue treatment among infants treated for retinopathy of prematurity and to evaluate their ocular outcomes at 18-24 months of corrected age.
METHODS: This is a single centre retrospective study of infants who received treatment for type 1 ROP, using laser photocoagulation or anti VEGF agents. Multivariable logistic regression was used to generate a prediction model for rescue treatment of ROP. The primary outcome was an abnormal refractive outcome by 24 months of corrected age, among infants primarily treated with laser therapy.
RESULTS: Two hundred and eight infants (including 416 eyes) who received single (n = 151) or rescue (multiple) treatments (n = 57) were included. Ninety three percent of the infants were primarily treated with laser photocoagulation. Lower gestational age, small for gestational age, early packed red blood cell transfusion (within 2 weeks of postnatal age), and presence of Zone 1 retinopathy predicted the need for rescue treatment in treated infants [area under the receiver operating characteristic curve: 0.81 (0.73-0.89)]. The incidence of abnormal refractive outcome, assessed in a total of 174 infants, was found to be significantly higher in the rescue treatment group (67% versus 21%, adjusted odds ratio: 7.56 (3.3-17.2), P < 0.001). Myopia, very high myopia and use of spectacles was significantly higher in the rescue treatment group (P < 0.001 for each).
CONCLUSIONS: Rescue treatment for ROP was associated with an increased incidence of refractive errors and requirement of spectacles by 2 years of age. Larger prospective multicentre studies are required to confirm the findings from our study.

Entities:  

Mesh:

Year:  2020        PMID: 32958871      PMCID: PMC8225667          DOI: 10.1038/s41433-020-01186-2

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   4.456


  6 in total

1.  Childhood blindness in the context of VISION 2020--the right to sight.

Authors:  C Gilbert; A Foster
Journal:  Bull World Health Organ       Date:  2003-07-07       Impact factor: 9.408

2.  Neurodevelopmental Outcomes of Preterm Infants With Retinopathy of Prematurity by Treatment.

Authors:  Girija Natarajan; Seetha Shankaran; Tracy L Nolen; Amaanti Sridhar; Kathleen A Kennedy; Susan R Hintz; Dale L Phelps; Sara B DeMauro; Waldemar A Carlo; Marie G Gantz; Abhik Das; Rachel G Greenberg; Noelle E Younge; Joseph M Bliss; Ruth Seabrook; Pablo J Sánchez; Myra H Wyckoff; Edward F Bell; Betty R Vohr; Rosemary D Higgins
Journal:  Pediatrics       Date:  2019-07-23       Impact factor: 7.124

3.  Thoracic osteomyelitis and epidural abscess formation due to cat scratch disease: case report.

Authors:  David Dornbos; Jocelyn Morin; Joshua R Watson; Jonathan Pindrik
Journal:  J Neurosurg Pediatr       Date:  2016-09-23       Impact factor: 2.375

Review 4.  Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.

Authors:  Mari Jeeva Sankar; Jhuma Sankar; Parijat Chandra
Journal:  Cochrane Database Syst Rev       Date:  2018-01-08

5.  Tumor Necrosis Factor-Alpha and the ERK Pathway Drive Chemerin Expression in Response to Hypoxia in Cultured Human Coronary Artery Endothelial Cells.

Authors:  Su-Kiat Chua; Kou-Gi Shyu; Yuh-Feng Lin; Huey-Ming Lo; Bao-Wei Wang; Hang Chang; Li-Ming Lien
Journal:  PLoS One       Date:  2016-10-28       Impact factor: 3.240

6.  Referrers' point of view on the referral process to neurosurgery and opinions on neurosurgeons: a large-scale regional survey in the UK.

Authors:  Meriem Amarouche; Jonathan J Neville; Simon Deacon; Nida Kalyal; Nikita Adams; Beverly Cheserem; Daniel Curley; Ruth-Mary DeSouza; Fehmi Hafiz; Tanya Jayawardena; Nishi Khetani; Diana Matthews; Sophie Mustoe; Sabrina Okafor; Olivia Padfield; Ishani Rao; Reem Samir; Hyder Tahir; Benjamin Varghese; Christos Michael Tolias
Journal:  BMJ Open       Date:  2017-11-26       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.